Vascular smooth muscle cells (VSMCs), although highly specialized, are not terminally di erentiated cells. ey maintain a great plasticity and, when stimulated by external inputs, they are able to switch to an activated phenotype characterized by increased cell proliferation capability and triggering of cell proliferation and migration programs [5, 6] .
ese properties are helpful for vascular healing following injury and damage, but can also be detrimental since they exert, a pivotal role in onset and progression of vascular proliferative disorders contributing to the thickening of the tunica intima, named neointima, and the beginning of the atherosclerotic plaque [7] . A wide range of elements contributes to VSMC activation and, among them, growth factors are the most critical ones. Platelet derived growth factor -BB (PDGF-BB), produced by activated platelets and macrophages, has so far been the only factor demonstrated to selectively and directly promote VSMC phenotype changes [5, 8] .
Following growth factor binding to its receptor, a cascade of kinases and phosphatases are activated and, within a few minutes, a series of events and speci c responses are triggered while the phosphorylation state of the proteins changes dramatically [9] . ese early events, even if phenotypically imperceptible, are decisive for the activation process in VSMCs [6, 10] , and result with a complete reorganization of the cell structure.
Indeed, several stimuli regulate both VSMC di erentiation and activation through phosphorylation [11] . Chen and colleagues in 2010 investigated the signal transduction pathways of aeat shock protein 27 (HSP27) phosphorylation in VSMCs a er angiotensin II (ANG-II) and PDGF-BB stimu-lation [12] . Similarly, Liu et al observed the promotion of VSMC proliferation via the phosphoinositol-3-kinase/ Protein Kinase B (PI3K/Akt) pathway induced by apelin-13 [13] . Recently, in an in vivo rat carotid injury model, overexpression of Smad3 produced an increase in phosphorylated extracellular signal-regulated kinases (ERK) mitogenactivated protein kinases (MAPK) as well as increased VSMC proliferation [14] .
Several MS-based quanti cation methods have been exploited for the study of the phosphoproteome [15, 16, 17] , highlighting how accuracy and reliability of phosphorylation sites identi cation and quantitation is of key importance. Among others, stable-isotope labeling of amino acids in cell culture (SILAC) is a simple and straightforward approach [18] , which allows the metabolic labeling in living cells and minimizes variations that could be introduced during sample preparation. However, some limitations still remain in a global phosphoproteomics approach, due to the low amount of phosphorylated proteins [19] , and these are overcome by the use of phosphopeptide enrichment methods [20, 21, 22] .
In this work, we used SILAC in a multi-strategy combined method for phosphopeptides enrichment in order to gain insights into the phospho-modulation of VSMC proteome stimulated by PDGF-BB. In particular, as the phosphorylation events are really fast and dynamic, we analyzed two di erent time points a er stimulation: 10 minutes and 2 hours. 1300 phosphopeptides, clustering into 380 protein groups were identi ed. Among them, 21 phosphopeptides (corresponding to 16 proteins) resulted phospho-modulated at di erent times upon PDGF-BB stimulation.
ese proteins are involved in cytoskeleton remodeling, focal adhesions, gap junction assembly and cell activation indicating that the events related to PDGF-BB phosphorylation pathway are the triggering phenomena in VSMC activation.
Material and methods

Chemicals, standards and consumables
ACN, water, formic acid used for LC-MS analysis were from Fluka, Sigma Aldrich St. Louis, MO; sequencing grade trypsin was purchased from Promega (Madison, WI). SI-LACTM DMEM medium, fetal bovine serum (FBS), Llysine, L-arginine, [13C6]-L-Lysine and [13C6]-L Arginine were purchased from Invitrogen (USA, CA). [U-13C6, U-15N2] Lysine and [U-13C6,U-15N4] Arginine were purchased at CIL (USA). Recombinant Human PDGF-BB was from R&D (USA). Coomassie Plus protein assay was from Pierce, Bio-Spin Column from Biorad and PHOS-Select Iron A nity Gel (IMAC resin) was purchased from Sigma Aldrich. All other chemicals were purchased from Sigma Aldrich.
Cell Culture and SILAC-Labeling
SILAC TM D-MEM medium containing 2 mM LGlutamine, 10% dialyzed FBS, and 100 U/mL penicillin and streptomycin was supplemented with 100 mg/L L-lysine and 100 mg/L L-arginine; 100 mg/L [ 13 C6]-L-Lysine and 100 mg/ L [ 13 C6]-L Arginine or 100 mg/L [U-13 C6, U-15 N2] Lysine and 100 mg/L [U-13 C6,U-15 N4] Arginine to prepare the "Light" (L), "Medium" (M)" or "Heavy" (H) SILAC culture media, respectively. VSMCs were obtained from coronaries of 8-month-old domestic crossbred pigs (Sus scrofa domestica) and the investigation was conformed to Ministerial Decree to authorize testing n.06/2009-b. Cells isolation was performed according to the method described by Christen et al [23] and VSMCs were expanded in SILAC medium for 6 doublings to ensure nearly 100% incorporation of labeled amino acids. For the experiments three biological replicates ( cells isolated from at least three di erent pieces of coronary coming from three di erent animals) and then pooled before analysis. Prior to cell treatment, all "heavy", "medium" and "light" cells were cultured overnight in their corresponding SILAC media without FBS. For PDGFtreatment, medium labeled cells (M) were treated for 10 minutes (t10min) with 100 ng/mL of PDGF-BB; heavy labeled cells (H) were stimulated for 2 hours (t2h) with PDGF-BB while Light labeled cells (L) were not treated with the growth factor (t0).
Protein lysate preparation and in-solution digestion
VSMCs were harvested with trypsin and lysed in 50mM Tris-HCl pH 8, 0.25% sodium deoxycholate, 0.5% Triton X100, 10mM sodium orthovanadate, 5mM sodium uoride. For each of three specimens (L, M and H cells), three million cells were re-suspended in 400 µl of lysis bu er. A er 30 min in ice, samples were sonicated and then centrifuged at 10000xg for 30 min at 4 °C to produce a clari ed lysate. L, M and H VSMC lysates were mixed at 1:1:1 [w/w] ratio, the protein amount was determined by Coomassie Plus protein assay. In total, 9 mg of the 1:1:1 mixed protein lysate was precipitated with a standard chloroform/methanol precipitation protocol. Precipitated proteins were re-suspended in 450 µl of 100 mM Tris-HCl pH 8.
Disul de bonds were reduced with 5 mM DTT for 60 min at room temperature, and then the free sul ydryl groups were alkylated with 10 mM iodoacetamide at room temperature in the dark for 30 min. Protein digestion was performed using a total of 18 µg of sequencing grade trypsin with 15 h incubation at 37°C.
Strong Cation Exchange (SCX) Chromatography
Preparative separations were carried out with SCX resin, using Bio-Spin Microcolumns. e rst equilibration resin step was carried out using 4.5 mL of solution A (5 mM KH 2 PO 4 , pH 2.65; 30% ACN; 0,1% TFA) for 5 min. en 4.5 mL of regeneration bu er were used (5mM KH 2 PO 4 , 30% ACN, 0.1% TFA, 1M KCl, pH 2.7). e rst step was repeated. e peptide mixtures were diluted with 4.5 mL of SCX solution A and placed on the resin at room temperature for 40 minutes. Increasing concentrations of solution B (5mM KH 2 PO 4 , 30% ACN, 0,1% TFA, 350mM KCl, pH 2.7) from 5% to 100% in 7 steps (5, 10, 15, 20 ,25, 50 , 100) were used to elute peptides.
Immobilized Metal-A nity Chromatography (IMAC)
PHOS-Select Iron A nity Gel was used for IMAC fractionation using the same microcolumn. As rst step, resin was washed three times with 200 μL of binding solution (0.1% TFA, 30% ACN ). 50μL of PHOS-Select slurry were added to each SCX fraction. A er 60-min incubation at room temperature with vigorous shaking, the supernatant was removed (IMAC ow-through). e resin was washed with 200 μL of binding solution and added to IMAC owthrough.
e mono-phosphorylated peptides and nonphosphorylated peptides were eluted from IMAC resin using acidic conditions (200 μL of 1% TFA, 20% ACN), while the poly-phosphorylated peptides were subsequently eluted from the same IMAC resin using ammonium hydroxide (200 μL of NH 4 OH pH 11.2). A er concentration (from 1mL to 0.1mL) in dry vacuum the pooled ow-through was further analyzed by TiO 2 chromatography.
e monophosphorylated peptide fraction was also subjected to TiO 2 chromatography as described below. Basic elution samples were submitted to LC-MS/MS analysis directly.
Titanium Dioxide (TiO2) Chromatography
Samples were diluted nine times with TiO 2 binding solution (5mg/mL DHB, 80% ACN and 3% TFA). 160 mg of TiO 2 resin were re-suspended in 1.4 mL of TiO 2 binding solution. 200µl of TiO 2 resin slurry were added to each sample for 30 min at room temperature. e supernatant was removed by centrifugation in a microcolumn. Non-speci c binders were removed by two washes with 500 µl of 50% ACN, 0.2% TFA solution. Phosphopeptides bound were eluted from TiO 2 micro-columns using 200 µL of ammonium hydroxide, 40% ACN pH 12.5 followed by 100 µL of 100% ACN.
Mass Spectrometry
Mass spectrometry analysis was performed on a LTQOrbitrap mass spectrometer ( ermo Scienti c, Bremen, Germany). Tryptic digests for each sample were cleaned using Stage Tips as described previously [24] and then injected in a capillary chromatographic system (EasyLC, Proxeon Biosystems, Denmark); Peptide separation occurred on a homemade column obtained with a 10-cm fused silica capillary (75 µm inner diameter and 360 µm outer diameter; Proxeon Biosystems) lled with 3 µm resin Reprosil-Pur C18 (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) using a pressurized "packing bomb". A gradient of eluents A (distilled water with 2% (v/v) ACN, 0.1% (v/v) formic acid) and B (2% (v/v) ACN, distilled water with 0.1% (v/v) formic acid) was used to achieve separation from 8% B (at 0 min, 0.2 µL-min ow rate) to 50% B (at 80 min, 0.2 µL-/min ow rate).
e LC system was connected to the Orbitrap equipped with a nanoelectrospray ion source (Proxeon Biosystems). Full-scan mass spectra were acquired in the mass range m/z 350 to 1500 and with the multistage activation enabled for neutral loss of phosphoric acid [32.66, 48 .99, and 97.97 atomic mass units (amu)] [25] . All full-scan spectra were recalibrated in real time with the lock-mass option [26] . e 5 most intense doubly and triply charged ions were automatically selected and fragmented in the ion trap.
Data analysis
e raw MS data were processed and analyzed using MaxQuant so ware version 1.0.13.13. e required FDR was set to 0.01 at both the peptide and protein level and the minimum required peptide length was set six amino acids. e MS/MS spectra were searched against Uniprot mammalia 2010_07 database supplemented by frequently observed contaminants, concatenated with reversed versions of all sequences. Mascot (version 2.2.07) was used for the database search. Enzyme speci city was set to trypsin, additionally allowing up to two missed cleavages.
e search included cysteine carbamidomethylation as xed modi cation and Nacetylation of protein, oxidation of methionine, and phosphorylation of serine, threonine and tyrosine as variable modi cations. Protein SILAC ratios are reported as the median of the ratios derived from SILAC triplets assigned to the protein. For phosphopeptides, the phosphorylation site(s) were assigned with a modi ed version of the PTM score [27] given in MaxQuant. MaxQuant automatically quanti ed SILAC peptides and proteins. SILAC protein ratios were calculated as the median of all peptide ratios assigned to the protein. Ratio Variability was less than 30%. Systematic deviations, such as mixing errors, were corrected by the quantitation algorithm in the MaxQuant so ware by normalizing all peptide ratios such that the mean of all log-transformed ratios were zero. A posterior error probability for each MS/ MS spectrum below or equal to 0.1 was required. In case the identi ed peptides of two proteins were the same or the identi ed peptides of one protein included all peptides of another protein, these proteins (e.g. isoforms and homologs) were combined and reported as one protein group. Phosphorylation sites were made non-redundant with regards to their surrounding peptide sequence. Nevertheless all alternative proteins that matched a particular phosphosite were reported as one group. e PTM score was used for assignment of the phosphorylation site(s) as described [27] . To match identi cations across di erent replicates and adjacent fractions, the "match between runs" option in MaxQuant was enabled within a time window of 5 min.
Bioinformatics analysis
We based the annotation of proteins on Uniprot identiers. Pathway membership information was obtained from the KEGG database (http://www.genome.jp/kegg/ pathway.html). Phospho_ELM BLAST Search PhosphoSite (http://phospho.elm.eu.org/pELMBlastSearch.html) database was used to retrieve known phosphorylated sites and relative kinases.
SILAC incorporation
For incorporation test, a small aliquot of cells was lysed using the above mentioned protocol. Brie y, 10μg of total lysate were loaded on SDS-PAGE. A section of the gel was digested with trypsin, and peptides were puri ed on StageTips and analyzed with a single LC-MS/MS run. Raw les were processed by MaxQuant analysis to determine the ratio of heavy labeled peptides to the remaining unlabeled ones.
e calculation for lysine-and arginine-containing peptides was performed separately. e probability density function analysis was obtained by kernel density estimation (KDE) using the R so ware package (ver. 2.10.1) (Figure 1 Supplementary data).
Results and Discussion
Work ow: description and assessment
In this study, we performed SILAC experiments to quantify changes in phosphorylation upon PDGF-BB stimulus. e schematic experimental work ow is depicted in Figure 1 . One advantage of SILAC is that it allows the combination of di erentially labeled protein samples early during sample preparation. is is especially important for the experiments related to this study because several sample fractionation and enrichment steps were involved. Our method combines SILAC for phosphopeptide quantitation, SCX fractionation, Figure 1 . Schematic work ow representation. Primary VSMCs, were cultured and stimulated with PDGF-BB at di erent time and di erent SILAC medium (L for t0; M for t10minand H for t2h ). Protein extracts were mixed 1:1:1 and enzymatically in solution digested. e resulting peptide mixtures were separated into 7 fractions by SCX fractionation. Every fraction was enriched for phosphopeptides using rst IMAC and then, TiO2 beads. Only the 14 di erent sample fractions obtained a er IMAC (7 fractions) and a er TiO2 (7 fractions) were analyzed by LC-MS/ MS (fractions marked with §). Two technical LC-MS/MS replicates were examined for each fraction. sequential elution from IMAC (SIMAC) [28] and multistage LC-MS to obtain a highly accurate phospho selection and identi cation. Primary VSMCs, obtained from pig coronary arteries, were cultured and stimulated with PDGF-BB (100 ng/mL) for 10 minutes and 2 hours and labeled with both arginine and lysine using three distinct isotope forms (L for t0, M for t10minand H for t2h ). Protein extracts were mixed 1:1:1 and enzymatically digested in solution. e resulting peptide mixtures were separated into 7 fractions by SCX [29] and phosphopeptides enriched by IMAC [30, 31] . Every fraction was enriched in phosphopeptides using rst IMAC and then, TiO2 beads.
Only the 14 di erent fractions obtained a er IMAC (7 fractions, see gure 1) and a er TiO2 (7 fractions, see gure 1) were analyzed by LC-MS/ MS, to speci cally identify phosphor-peptides and proteins. Two replicates of each fraction were examined by online liquid chromatography on a linear ion trap/Orbitrap mass spectrometer. Each peptide was eluted as characteristic triplets: one peptide unlabeled for t0 and the other two peptides di erently labeled on arginine or lysine for the two di erent PDGF-BB stimulation times (t10min and t2h). e intensity of each component of triplet re ects the relative amounts at the three time points chosen. Technical reproducibility of SILAC quanti cation for each peptide was proved to be really excellent (R2 > 0.93) (Figure 2-Supplementary data) .
Comparing results in terms of phosphopeptides identi cation, TiO2 selection enable the identi cation of 86% of the total phosphopeptides, with only 12% overlapping with IMAC selection (Figure 2A) .
Considering that the SILAC approach was applied for the rst time to VSMC model to quantitatively analyze timecourse modi cations, we evaluated the level of labeled amino acid incorporation in these primary cells and the possible cellular morphological changes induced by the treatments. Labeling e ciency, calculated separately for lysine-and for arginine-containing peptides, was very high, above 96% for both labeled samples (M and H ) (Figure 1 , panel ASupplementary data) demonstrating both the feasibility of SILAC quantitation in primary VSMCs and the precision of the experiment (Figure 1 , panel B_Supplementary data). Moreover, confocal microscope images obtained staining VSMCs with the speci c marker a-SM-actin showed no di erences in cell morphology and/or marker distribution in cells grown in the three SILAC media compared to those cultured in standard conditions (data not shown). 
Phosphoproteome analysis of PBGF-BB stimulated VSMCs
Quantitation of phosphorylation sites was obtained via MaxQuant analysis [32] . A total of 42 LC-MS/MS analyses allowed the identi cation of a total of 1300 phosphopeptides distributed on 380 protein groups (see Supplementary Table  1 and 2) . Although satisfactory, these data are underestimated owing to the partial completion of the Sus scrofa database [33] . In order to compensate this shortcoming we used the Uniprot cp mammalia database to identify not only phosphopeptides belonging to Sus scrofa but also phosphorylated peptides highly homologous in other mammalian species ( Figure 2B ).
Phospho_ELM BLAST Search PhosphoSite was used to look for novel, still unidenti ed, phosphorylated sites. Among the non-redundant 113 phosphorylated sites identied, 42% (corresponding to 47 new phosphorylation sites) were not yet previously reported in Mouse-Human database (identi ed through sequence homology between Pig and Mouse-Human) (see Supplementary Table 1 and Figure 2D ). For the phospho-modulated proteins, more than 50% of the sites were identi ed as new in the Mouse-Human database.
It is worth noting that all identi ed phosphorylation sites are not present in the Sus Scrofa database highlighting the great drawback of using pig as a model organism. Notwith- Table 1 . Di erentially phosphorylated peptides. Proteins corresponding to the peptides are reported in the rst column. e numbers of phosphorylation sites, the putative amino-acidic phosphorylated residues, the enzymes likely involved in the phosphorylations are indicated. e columns tagged as 10min and 2h quote the phosphorylation trend at 10 minutes or 2 hours a er stimulation (▲; up-regulated, ▼; down-regulated) . e last two columns report the information on the known phosphorylation site.
standing, pig remains an important animal model for cardiovascular disease experimentations and thus it could be valuable to annotate the database with our ndings. Using 1.7 fold as SILAC ratio cuto (corresponding to P < 0.05 as calculated by MaxQuant signi cance B and using the ratio M/L and H/L normalized by MaxQuant on median intensity), we found 21 phosphopeptides statistically modulated at di erent times of stimulation (Table 1, Figure 3 ) . Ten of them (belonging to 6 di erent proteins) were upregulated, while the remaining eleven (belonging to 10 di erent proteins) resulted to be down-regulated upon PGDF-BB stimulation at both time points.
One potential concern for quantitative phosphoproteomics is that changes in protein expression can a ect phosphopeptide/phosphoprotein ratios. In our SILAC analyses, for each replicate, we used the same cell population under the same growing conditions. At the last passage, cells were subdivided in three groups, all of them cultured for 24h without serum and a erwards two parts were treated with PDGF-BB as indicated while the thirdset of cells was le untreated. e time of treatment was short and thus we reasoned that it would not lead to signi cant changes in protein expression.
is hypothesis was also con rmed from the analysis of the ratio M/L and H/L of the entire proteome identi ed ( Figure 3 and 4-Supplementary data.) Before harvesting, cells were counted in order to use in the successive analyses the same number of them for each treatment.
KEGG pathway analysis of the identi ed phosphoproteins revealed that phosphorylation events in the activation process induced by PDGF-BB are involved in several functions including RNA and protein processing, extra cellular matrix (ECM)-receptor interaction, VSMC contraction, gap junction regulation and oxidative phosphorylation ( Figure 2C ). e most represented functions (RNA and protein processing) are related to transcription and translation activities.
is last observation is interesting since the early events (from 10 min to 2h of growth factor stimulation) are initial stages towards the acquisition of the activated, synthetic phenotype which extensively engaged in new proteins synthesis.
Finally, it is interesting , the analysis of the kinases potentially involved in the activation process induced by PDGF-BB . Figure 4 shows the results of phosphopeptides that were predicted to be associated with kinase binding motif by SCANSITE. e computer algorithm SCANSITE was used to predict the kinase substrate relationship from dataset. e panel A shows the known motif distribution for all identi ed phosphorylation sites. e panel B shows instead the same analysis restricted for the sites of modulated proteins in our "in vitro" cardiovascular pathogenesis model. e analysis of the most frequent protein kinase related with the phosphomodulated proteins were normalized in order to better analyze the frequency of phosphorylation motif in our system. (Figure 4 
panel C)
It is interesting to note that Ca2+/calmadulin-dependent protein kinases 2 (CAMK2), cyclin-dependent kinase 2 (CDK2) and casein kinase 1 (CK1) appear to be mainly involved in the signaling evoked during VMSC activation induced by PGDF-BB. In particular, the modulation of HSP27 and gap junction a-1 protein (connexin 43), seems to be relevant for VSMC phenotype changes. HSP27 has been recently demonstrated to be phosphorylated a er PDGF-BB stimulation and to exert a role in VSMC de-di erentiation through cytoskeleton remodeling [34] .
Connexin 43 is the major protein of gap junctions and it is highly expressed in the neointima during the early stage of arteriosclerosis [35, 36] . It has been shown that connexin 43 phosphorylation can regulate the early assembly of functional gap junctional channels [37] . It is also worth discussing the modulation of other proteins such as calreticulin, lamin A (FLNA), PDZ LIM protein 5 and vinculin, since also the modulation of these proteins might be involved in VSMC activation. Vinculin is a membrane protein that links adhesion molecules to actin cytoskeleton and has a key role in modulating focal adhesion structures and functions thus controlling cell migration. e phosphorylation of Vinculin on tyrosine and serine is well-known and seems to regulate actin lament assembly and cell spreading [38, 39, 40] . Also the PDZ and LIM domain protein family is involved in focal adhesion assembly [41] . LIM and PDZ domains may have diverse functions but essentially they provide recognition sites for assembling multiprotein complexes and cytoskeleton. Noteworthy, PDZ-domain-containing proteins serve as sca olds for assembling complexes involved in cellcell junctions and signal transduction [42, 43] .
e extent and role of phosphorylation in modulating the biological functions of these proteins has been poorly investigated.
Caldesmon is an actin-binding protein that plays an essential role in the regulation of cytoskeleton organization modulating VSMC contraction and stabilizing stress bers and focal adhesions. It has been demonstrated that phosphorylation decreases its actin-binding capacity thereby allowing dynamic changes of actin cytoskeleton that lead to motility and likely activation [44] .
Also lamin A is an actin-binding protein and it regulates re-organization of cytoskeleton. It is essential for cell locomotion, interacting with integrins and membrane receptor complexes in VSMCs [45, 46] . Recently, it has been shown that phosphorylated lamin A regulates actin-linked caveolae dynamics [47] , moreover, phosphorylation seems to facilitate lamin A binding to integrin suggesting a role, modulated by the degree of phosphorylation, as a mechano-sensor [48] .
Calreticulin is an endoplasmic reticulum-resident chaperone that binds misfolded proteins and prevents them from being exported, but it is also found in the nucleus and thus may have a role in transcription regulation. More recently, an important role of serine de-phosphorylation and tyrosine phosphorylation on mRNA stability of angiotensin II receptor type 1 (AT1) receptor was investigated [49] . is receptor mediates important biological e ects in VSMCs, such as proliferation, vasoconstriction and reactive oxygen species release [50] . It is interesting to underline that up-and downphosphorylation events are equally represented at early times a er stimulation. Probably, once PDGF-BB growth factor binds to its receptor, within a few minutes a cascade of kinases and phosphatases activate a series of biological events and the phosphorylation state of several proteins changes dramatically. As discussed previously, these early events, even if phenotypically imperceptible, are decisive for the activation process in VSMCs [6, 10] , and the entire reorganization of the cell structure.
Concluding Remarks
In summary, we performed for the rst time a quantitative phosphoproteome analysis on primary VSMCs in order to investigate biological events induced by PDGF-BB stimulation. Moreover, the SILAC approach applied to VSMC model allowed evaluation of time-course modi cations in a quantitative manner. Our approach allowed the identi cation of 1300 phosphopeptides, one hundred of them resulted novel phospho-sites in pig model, 47 of which are new even in MouseHuman databases. Furthermore, in VSMC signaling events, some important factors involved in cytoskeleton remodeling, focal adhesions, gap junction assembly and cell activation were found di erentially phosphorylated these early phosphorylations, pointed out here for the rst time can be considered the starting point for the activation and the reorganization of VSMC. 
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